10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELI LILLY & CO | |||
Ticker: LLY Fiscal Year: 2022 | |||
Consolidated Statements of Operations | |||
Period Ending Dec 31, 2022 10-K (Filed: Feb 22, 2023) | |||
| (In Thousands) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
| Revenue (Note 2) | $ 28,541,400 | 28,318,400 | 24,539,800 |
| Costs, expenses, and other: | |||
| Cost of sales | 6,629,800 | 7,312,800 | 5,483,300 |
| Research and development | 7,190,800 | 6,930,700 | 5,976,300 |
| Marketing, selling, and administrative | 6,440,400 | 6,431,600 | 6,121,200 |
| Acquired in-process research and development and development milestones (Note 3) | 908,500 | 970,100 | 769,800 |
| Asset impairment, restructuring, and other special charges (Note 5) | 244,600 | 316,100 | 131,200 |
| Othernet, (income) expense (Note 18) | 320,900 | 201,600 | (1,171,900) |
| Costs, expenses, and other | 21,735,000 | 22,162,900 | 17,309,900 |
| Income before income taxes | 6,806,400 | 6,155,500 | 7,229,900 |
| Income taxes (Note 14) | 561,600 | 573,800 | 1,036,200 |
| Net income | 6,244,800 | 5,581,700 | 6,193,700 |
| Earnings per share: | |||
| Basic (in dollars per share) | 6.93 | 6.15 | 6.82 |
| Diluted (in dollars per share) | 6.90 | 6.12 | 6.79 |
| Shares used in calculation of earnings per share: | |||
| Basic (in shares) | 901,736 | 906,963 | 907,634 |
| Diluted (in shares) | 904,619 | 911,681 | 912,505 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELI LILLY & CO | |||
Ticker: LLY Fiscal Year: 2022 | |||
Consolidated Statements of Comprehensive Income (Loss) | |||
Period Ending Dec 31, 2022 10-K (Filed: Feb 22, 2023) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
| Net income | $ 6,244,800 | 5,581,700 | 6,193,700 |
| Other comprehensive income (loss): | |||
| Change in foreign currency translation gains (losses) | (248,100) | 13,500 | 122,100 |
| Change in net unrealized gains (losses) on securities | (53,200) | (15,900) | 14,200 |
| Change in defined benefit pension and retiree health benefit plans (Note 15) | 616,900 | 2,699,400 | (157,100) |
| Change in effective portion of cash flow hedges | 432,900 | 151,600 | (152,900) |
| Other comprehensive income (loss) before income taxes | 748,500 | 2,848,600 | (173,700) |
| Benefit (provision) for income taxes related to other comprehensive income (loss) | (250,000) | (695,300) | 200,900 |
| Other comprehensive income, net of tax (Note 17) | 498,500 | 2,153,300 | 27,200 |
| Comprehensive income | 6,743,300 | 7,735,000 | 6,220,900 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELI LILLY & CO | |||
Ticker: LLY Fiscal Year: 2022 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2022 10-K (Filed: Feb 22, 2023) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
| Cash Flows from Operating Activities | |||
| Net income | $ 6,244,800 | 5,581,700 | 6,193,700 |
| Adjustments to Reconcile Net Income to Cash Flows from Operating Activities: | |||
| Depreciation and amortization | 1,522,500 | 1,547,600 | 1,323,900 |
| Debt extinguishment loss (Note 11) | 0 | 405,200 | 0 |
| Change in deferred income taxes | (2,185,200) | (802,300) | (134,500) |
| Stock-based compensation expense | 371,100 | 342,800 | 308,100 |
| Net investment (gains) losses | 420,000 | (178,000) | (1,438,500) |
| Acquired in-process research and development and development milestones (Note 3) | 420,900 | 874,900 | 660,400 |
| Other non-cash operating activities, net | 304,800 | 511,400 | 333,900 |
| Other changes in operating assets and liabilities, net of acquisitions and divestitures: | |||
| Receivables(increase) decrease | (299,600) | (1,278,300) | (1,350,200) |
| Inventories(increase) decrease | (599,700) | (235,900) | (533,400) |
| Other assets(increase) decrease | (793,500) | 1,515,400 | (457,100) |
| Income taxes payableincrease (decrease) | 346,600 | (359,700) | 322,000 |
| Accounts payable and other liabilitiesincrease (decrease) | 1,331,700 | (664,100) | 1,271,300 |
| Net Cash Provided by Operating Activities | 7,084,400 | 7,260,700 | 6,499,600 |
| Cash Flows from Investing Activities | |||
| Purchases of property and equipment | (1,854,300) | (1,309,800) | (1,387,900) |
| Proceeds from sales and maturities of short-term investments | 121,400 | 47,400 | 129,700 |
| Purchases of short-term investments | (107,400) | (83,500) | (11,400) |
| Proceeds from sales of noncurrent investments | 342,200 | 800,000 | 757,100 |
| Purchases of noncurrent investments | (600,200) | (929,900) | (358,700) |
| Purchases of in-process research and development | (629,700) | (563,400) | (641,200) |
| Cash paid for acquisitions, net of cash acquired (Note 3) | (327,200) | (747,400) | (849,300) |
| Other investing activities, net | (206,400) | 24,300 | 102,800 |
| Net Cash Used for Investing Activities | (3,261,600) | (2,762,300) | (2,258,900) |
| Cash Flows from Financing Activities | |||
| Dividends paid | (3,535,800) | (3,086,800) | (2,687,100) |
| Net change in short-term borrowings | 1,498,000 | (4,000) | (1,494,200) |
| Proceeds from issuance of long-term debt | 0 | 2,410,800 | 2,062,300 |
| Repayments of long-term debt | (1,560,000) | (1,905,400) | (276,500) |
| Purchases of common stock | (1,500,000) | (1,250,000) | (500,000) |
| Other financing activities, net | (308,900) | (295,900) | (241,600) |
| Net Cash Used for Financing Activities | (5,406,700) | (4,131,300) | (3,137,100) |
| Effect of exchange rate changes on cash and cash equivalents | (167,600) | (205,700) | 216,000 |
| Net increase (decrease) in cash and cash equivalents | (1,751,500) | 161,400 | 1,319,600 |
| Cash and cash equivalents at beginning of year | 3,818,500 | 3,657,100 | |
| Cash and Cash Equivalents at End of Year | 2,067,000 | 3,818,500 | 3,657,100 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELI LILLY & CO | ||
Ticker: LLY Fiscal Year: 2022 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2022 10-K (Filed: Feb 22, 2023) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2022 | Dec 31, 2021 | |
| Assets | ||
| Current Assets | ||
| Cash and cash equivalents (Note 7) | $ 2,067,000 | 3,818,500 |
| Short-term investments (Note 7) | 144,800 | 90,100 |
| Accounts receivable, net of allowances of $16.0 (2022) and $22.5 (2021) | 6,896,000 | 6,672,800 |
| Other receivables | 1,662,900 | 1,454,400 |
| Inventories (Note 6) | 4,309,700 | 3,886,000 |
| Prepaid expenses and other current assets | 2,954,100 | 2,530,600 |
| Total current assets | 18,034,500 | 18,452,400 |
| Investments (Note 7) | 2,901,800 | 3,212,600 |
| Goodwill (Note 8) | 4,073,000 | 3,892,000 |
| Other intangibles, net (Note 8) | 7,206,600 | 7,691,900 |
| Deferred tax assets (Note 14) | 2,792,900 | 2,489,300 |
| Property and equipment, net (Note 9) | 10,144,000 | 8,985,100 |
| Other noncurrent assets | 4,337,000 | 4,082,700 |
| Total assets | 49,489,800 | 48,806,000 |
| Liabilities and Equity | ||
| Current Liabilities | ||
| Short-term borrowings and current maturities of long-term debt (Note 11) | 1,501,100 | 1,538,300 |
| Accounts payable | 1,930,600 | 1,670,600 |
| Employee compensation | 1,059,800 | 958,100 |
| Sales rebates and discounts | 8,784,100 | 6,845,800 |
| Dividends payable | 1,017,200 | 885,500 |
| Income taxes payable (Note 14) | 475,100 | 126,900 |
| Other current liabilities | 2,370,300 | 3,027,500 |
| Total current liabilities | 17,138,200 | 15,052,700 |
| Other Liabilities | ||
| Long-term debt (Note 11) | 14,737,500 | 15,346,400 |
| Accrued retirement benefits (Note 15) | 1,305,100 | 1,954,100 |
| Long-term income taxes payable (Note 14) | 3,709,600 | 3,920,000 |
| Deferred tax liabilities (Note 14) | 87,300 | 1,733,700 |
| Other noncurrent liabilities | 1,736,700 | 1,644,300 |
| Total other liabilities | 21,576,200 | 24,598,500 |
| Commitments and Contingencies (Note 16) | ||
| Eli Lilly and Company Shareholders' Equity (Notes 12 and 13) | ||
| Common stockno par value Authorized shares: 3,200,000 Issued shares: 950,632 (2022) and 954,116 (2021) | 594,100 | 596,300 |
| Additional paid-in capital | 6,921,400 | 6,833,400 |
| Retained earnings | 10,042,600 | 8,958,500 |
| Employee benefit trust | (3,013,200) | (3,013,200) |
| Accumulated other comprehensive loss (Note 17) | (3,844,600) | (4,343,100) |
| Cost of common stock in treasury | (50,500) | (52,700) |
| Total Eli Lilly and Company shareholders' equity | 10,649,800 | 8,979,200 |
| Noncontrolling interests | 125,600 | 175,600 |
| Total equity | 10,775,400 | 9,154,800 |
| Total liabilities and equity | 49,489,800 | 48,806,000 |
| External Links | |
| ELI LILLY & CO (LLY) Fiscal Year 2022 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |